Myda Advisors LLC Sorrento Therapeutics, Inc. Transaction History

Myda Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$2.67 - $4.38 $26,700 - $43,800	-10,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$1.86 - $5.94 $18,600 - $59,400	10,000 New	10,000 $48,000
Q3 2018 Nov 14, 2018	SELL	$4.22 - $7.5 $147,700 - $262,500	-35,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$4.75 - $8.0 $166,250 - $280,000	35,000 New	35,000 $252,000
Q1 2018 May 10, 2018	SELL	$4.5 - $9.95 $135,000 - $298,500	-30,000 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$1.75 - $3.8 $52,500 - $114,000	30,000	30,000 $114,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.